Overview
Randomised, single-blind clinical trial comparing chlorhexidine gluconate-impregnated transparent dressings versus conventional transparent dressings in the prevention of central venous catheter-related bloodstream infections (CVC-BSI) in paediatric patients admitted to a tertiary hospital PICU. Outcomes include incidence of BRCVC, catheter colonisation, dressing-related skin complications, and number of dressing changes.
Eligibility
Inclusion Criteria:
- Admission to paediatric intensive care unit (PICU)
- Central venous catheter placement (central or peripherally inserted)
- Informed consent obtained from parent/legal guardian
Exclusion Criteria:
- Known immunological disorders
- Neutropenia (<500/mm³)
- Pre-existing colonisation or infection with multidrug-resistant organisms